View all the latest news stories and events from HEE
19th September, 2019
Health Enterprise East is pleased to announce its partnership with the Royal Devon and Exeter NHS Foundation Trust, a top-ranked NHS Trust employing around 8,000 staff and serving a population of over 460,000 people in Exeter, East Devon and Mid-Devon.
28th August, 2019
The Medtech Accelerator has announced awards totalling £150,000 to two innovations in the fields of critical care logistics and cornea replacement surgery.
11th July, 2019
Applications are now open for the latest Health Enterprise East Innovation Voucher Competition, which will reward the most novel ideas in medtech innovation with vouchers of up to £5,000 each.
20th February, 2019
SBRI Healthcare has awarded £1.25 million to help fund the development of thirteen separate innovations relating to musculoskeletal disorder and dentistry, oral health and oral cancers
12th February, 2019
Medical device development company and innovation partner to Health Enterprise East, Medovate, has recently announced that it has secured the exclusive rights to design, develop, and manufacture Arterial Glucosave.
21st December, 2018
Health Enterprise East are pleased to announce its first licence agreement with medical device company Medovate.
19th December, 2018
Health Enterprise East is pleased to announce it has entered into a unique partnership with University Hospital Southampton NHS Foundation Trust (UHS).
14th November, 2018
Health Enterprise East is pleased to report on the company’s first ever MedTech FUTURES Conference
5th November, 2018
Dr. Anne Blackwood, CEO, Health Enterprise East (HEE), has been named as an outstanding female leader in the bioscience industry in BioBeat’s 2018 “50 Movers and Shakers in BioBusiness” report.
31st August, 2018
Health Enterprise East (HEE) is pleased to announce its newest member trust, University Hospital Southampton NHS Foundation Trust.
18th July, 2018
With increasing pressure on surgical services, the cost of delivering surgery and patient waiting times, new technology offers the potential to extend the capabilities of surgeons by elevating the level of precision and improving procedure efficiency.
10th June, 2018
NVM Private Equity (“NVM”) has invested £1.0 million of growth capital into Cambridge-based medical device company Ablatus Therapeutics (“Ablatus”) alongside existing angel investors.
23rd May, 2018
Health Enterprise East (HEE) are pleased to announce the expansion of its best-in-class medtech consulting services: MedTech CONSULTING
Keep up to date with all HEE news and events.